This topic contains a solution. Click here to go to the answer

Author Question: Mycobacterium fortuitum is classified as a A) nonphotochromogen. B) scotochromogen. C) rapid ... (Read 84 times)

s.tung

  • Hero Member
  • *****
  • Posts: 577
Mycobacterium fortuitum is classified as a
 
  A) nonphotochromogen. B) scotochromogen.
  C) rapid grower. D) photochromogen.

Question 2

An individual who exhibits rash and hives on starting treatment with penicillin may also exhibit these same symptoms with
 
  A) monobactams. B) vancomycin. C) cephalosporins. D) carbapenems.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

SAUXC

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

C

Answer to Question 2

C




s.tung

  • Member
  • Posts: 577
Reply 2 on: Jun 25, 2018
YES! Correct, THANKS for helping me on my review


bblaney

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library